Effect of homoeopathic medicine on sleep and blood sugar levels in people with type 2 diabetes mellitus having sleeplessness

A prospective interventional study on the effect of individualized homoeopathic treatment on sleep quality and glycemic control in type 2 diabetes mellitus patients with insomnia - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/098110

Enrollment

Registered

2025-11-26

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: Individualized homoeopathic medicine: Individualized homoeopathic medicine for 6 months in different potency according to patients need Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Type 2 Diabetes Mellitus according to American diabetes association 2024 criteria Patients of type 2 diabetes mellitus meeting DSM 5 or ICSD 3 criteria for insomnia for at least 3 months Patients with HbA1c levels ranging from 6.5 to 7.5 percentage Patients of age 30 to 65 years of age irrespective of their gender race religion and socio- economic status Pittsburgh sleep quality index score more than 5 Patient capable of giving informed consent willingness and ability to comply with scheduled visits treatment plans and other study procedures Patients who are able to understand and communicate in the language used for data collection and consultations

Exclusion criteria

Exclusion criteria: Patients with type 1 Diabetes Mellitus or other forms of secondary diabetes Patients currently on insulin therapy or using any form of complementary or alternative medicine other than homeopathy for the management of diabetes or sleep disorders Shift workers or individuals with irregular sleep patterns due to lifestyle or occupational reasons. Patients who use sleep medications or antidepressants Patients with unstable psychiatric illness uncontrolled or life-threatening medical conditions or clinically diagnosed complications related to type 2 diabetes mellitus that may affect quality of life Pregnant or lactating women Patients on substance abuse

Design outcomes

Primary

Measure	Time frame
pittsburgh sleep quality index scoreTimepoint: At baseline and 6 months	—

Secondary

Measure	Time frame
HbA1c levelsTimepoint: Baseline and 6 months	—

Countries

India

Contacts

Public ContactProf Dr Gautam pal

National Institute of Homoeopathy

inturi.lakshmi98@gmail.com8341839339

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026